Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|April 24, 2019
Prevalence and Outcome of Secondary Hemophagocytic Lymphohistiocytosis Among SIRS Patients: Results from a Prospective Cohort StudyGuido A Gualdoni, Georg A Hofmann, Philipp Wohlfarth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5)Wolfgang R Sperr, Maria Piribauer, Friedrich Wimazal, et al.
Annals of Hematology|September 16, 2020
Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment responseSvitlana Demyanets, Alexandra Kaider, Ingrid Simonitsch-Klupp, et al.
British Journal of Haematology|April 26, 2002
Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery diseaseGeorg Endler, Alexandra Klimesch, Heike Sunder-Plassmann, et al.
Annals of Hematology|May 28, 2011
Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximabMichaela Gruber, Karin Fleiss, Edit Porpaczy, et al.
Clinical Chemistry and Laboratory Medicine|April 26, 2026
Post-transplant ring sideroblasts are common in haploidentical peripheral blood stem cell transplantation but not linked to SF3B1 mutationsMarlene Hollenstein, Theresa Allerstorfer, Julia Flandorfer, et al.
Leukemia Research Reports|March 6, 2014
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816HPeter Valent, Katharina Blatt, Gregor Eisenwort, et al.
Frontiers in Neurology|May 1, 2024
Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MSTobias Zrzavy, Kerstin Rieder, Viktoria Wuketich, et al.
American Journal of Hematology|January 2, 2023
N-terminal pro-brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemiaIrene Graf, Georg Greiner, Rodrig Marculescu, et al.
American Journal of Cancer Research|April 1, 2021
Impact of HFE gene variants on iron overload, overall survival and leukemia-free survival in myelodysplastic syndromesMathias Schneeweiss-Gleixner, Georg Greiner, Susanne Herndlhofer, et al.
Pageof 4